109 related articles for article (PubMed ID: 15589770)
1. Evidence about extending the duration of oral contraceptive use to suppress menstruation.
Hitchcock CL; Prior JC
Womens Health Issues; 2004; 14(6):201-11. PubMed ID: 15589770
[TBL] [Abstract][Full Text] [Related]
2. [Oral contraceptives: knowledge and compliance].
Koch T; Marslew U; Nielsen MR
Ugeskr Laeger; 1993 Nov; 155(44):3546-50. PubMed ID: 8236575
[TBL] [Abstract][Full Text] [Related]
3. Cycle control and side effects of a new combiphasic oral contraceptive regimen.
Dieben TO; op ten Berg MT; Coelingh Bennink HJ
Arzneimittelforschung; 1994 Jul; 44(7):877-9. PubMed ID: 7945527
[TBL] [Abstract][Full Text] [Related]
4. Women's attitudes to withdrawal bleeding and their knowledge and beliefs about the oral contraceptive pill.
Rutter W; Knight C; Vizzard J; Mira M; Abraham S
Med J Aust; 1988 Oct; 149(8):417-9. PubMed ID: 3173203
[TBL] [Abstract][Full Text] [Related]
5. Communicating with patients about extended-cycle and continuous use of oral contraceptives.
Nelson AL
J Womens Health (Larchmt); 2007 May; 16(4):463-70. PubMed ID: 17521249
[TBL] [Abstract][Full Text] [Related]
6. Extended-cycle oral contraception: a new option for routine use.
Nelson AL
Treat Endocrinol; 2005; 4(3):139-45. PubMed ID: 15898819
[TBL] [Abstract][Full Text] [Related]
7. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
8. Women's knowledge of taking oral contraceptive pills correctly and of emergency contraception: effect of providing information leaflets in general practice.
Smith LF; Whitfield MJ
Br J Gen Pract; 1995 Aug; 45(397):409-14. PubMed ID: 7576845
[TBL] [Abstract][Full Text] [Related]
9. [Triella: a French multicenter double blind clinical study].
Castaigne JP
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):445-53. PubMed ID: 12280213
[TBL] [Abstract][Full Text] [Related]
10. A new ultra-low-dose combination oral contraceptive.
Woutersz TB
J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of the menstrual cycle after discontinuation of oral contraceptives.
Nassaralla CL; Stanford JB; Daly KD; Schneider M; Schliep KC; Fehring RJ
J Womens Health (Larchmt); 2011 Feb; 20(2):169-77. PubMed ID: 21219248
[TBL] [Abstract][Full Text] [Related]
12. Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse).
Barbosa IC; Filho CI; Faggion D; Baracat EC
Contraception; 2006 Jan; 73(1):30-3. PubMed ID: 16371291
[TBL] [Abstract][Full Text] [Related]
13. [Long-cycle treatment in oral contraception].
Kuhl H; Birkhäuser M; Mueck A; Neulen J; Thaler C; Kiesel L; Braendle W
Ther Umsch; 2009 Feb; 66(2):101-8. PubMed ID: 19180430
[TBL] [Abstract][Full Text] [Related]
14. Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms.
Sulak PJ; Cressman BE; Waldrop E; Holleman S; Kuehl TJ
Obstet Gynecol; 1997 Feb; 89(2):179-83. PubMed ID: 9015017
[TBL] [Abstract][Full Text] [Related]
15. Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms.
Sulak PJ; Kuehl TJ; Ortiz M; Shull BL
Am J Obstet Gynecol; 2002 Jun; 186(6):1142-9. PubMed ID: 12066088
[TBL] [Abstract][Full Text] [Related]
16. Long-cycle treatment with oral contraceptives.
Wiegratz I; Kuhl H
Drugs; 2004; 64(21):2447-62. PubMed ID: 15482002
[TBL] [Abstract][Full Text] [Related]
17. Comparison of a paper pill with a conventional oral contraceptive tablet.
Basu HK; Edwards C
J Int Med Res; 1980; 8(2):148-52. PubMed ID: 7371971
[TBL] [Abstract][Full Text] [Related]
18. [Effects and side effects of hormonal contraceptives].
Carol W; Göretzlehner G
Z Arztl Fortbild (Jena); 1980 Feb; 74(3):97-104. PubMed ID: 7415248
[TBL] [Abstract][Full Text] [Related]
19. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
Kamal I; Hefnawi F; Younis N
Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
[TBL] [Abstract][Full Text] [Related]
20. Hormone withdrawal symptoms in oral contraceptive users.
Sulak PJ; Scow RD; Preece C; Riggs MW; Kuehl TJ
Obstet Gynecol; 2000 Feb; 95(2):261-6. PubMed ID: 10674591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
